Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
flow chart for decision to hospitalize for CAP
|
if pt > 50 yo--> assign pt to risk class II-IV according to points sheet
if pt less than 50 yo and has one of the following: cancer, CHF, cerebrovascular disease, renal or liver disease then assign class II-IV if not, assign risk class I if they have any of the following: AMS pulse > 125 RR> 30 systolic BP less than 90 Temp less than 35 or greater than 40 |
|
CURB-65- what's it stand for
|
C: Confusion (MMSE ≤8, new disorientation to person, place, or time)
U: Uremia (BUN >20 mg/dL R: Respiratory Rate ≥ 30/minute B: Diastolic BP ≤ 60 mmgHg or Systolic BP < 90 mmHg 65: Age ≥ 65 |
|
how to interpret CURB score (3) what's it used for
|
0-1: Probably suitable for home treatment; low risk of death
2: Consider hospital supervised treatment ≥3: Manage in hospital as severe pneumonia; high risk of death to determine if you are sending home or not |
|
CAP needs to be treated within...
|
Treat within 24-48hrs
|
|
drug for CAP if no comorbid conditions and no use of antimicrobials within the previous 3 months (1 drug class, 1 alternative)
|
macrolide (azithromycin, clarithromycin, or erythromycin)—doxycycline alternative (weak evidencE)
|
|
7 "Comorbidities" that would change how you treat CAP
|
chronic heart, lung, liver or renal disease, DM, alcoholism, malignancies, asplenia, immunosuppressing conditions or drugs, antimicrobial use within last 3mo
|
|
2 options for treating CAP in pt with comorbidities
|
A respiratory fluoroquinolone (moxifloxacin, gemifloxacin, or levofloxacin )- just means they are strong against respiratory pathogens- first line
A β-lactam plus a macrolide (or doxycycline instead of macrolide but weak evidence) |
|
preferred beta lactam
alternatives (3) |
High-dose amoxicillin [e.g., 1 g 3 times daily] or amoxicillin-clavulanate [2 g 2 times daily] is preferred; alternatives include ceftriaxone, cefpodoxime, and cefuroxime
|
|
. In regions with a high rate (>25%) of infection with high-level(MIC _16 mg/mL) macrolide-resistant Streptococcus pneumoniae, consider use of what instead?
|
doxycycline in place of macrolide
|
|
Inpatients, non-ICU treatment for CAP (2)
|
A respiratory fluoroquinolone (strong recommendation; level I evidence)
A β-lactam plus a macrolide (strong recommendation; level I evidence) |
|
Suggest causes of non-response in a patient with community acquired pneumonia. (4)
|
Resistant microorganism, nosocomial superinfection, parapneumonic effusion/empyema or noninfectious complication of pneumonia is present
|
|
7 s/sx of flu
|
Fever over 100 F (38 C)
Aching muscles, especially in your back, arms and legs Chills and sweats Headache Dry cough Fatigue and weakness Nasal congestion |
|
State the pathogens commonly associated with community acquired pneumonia in adults for outpatients (5)
|
Streptococcus pneumoniae Mycoplasma pneumoniae Haemophilus influenzae Chlamydia pneumoniae Respiratory viruses
|
|
Pathogens for inpatients (6- same as outpatient but one more)
|
Streptococcus pneumoniae Mycoplasma pneumoniae Chlamydia pneumoniae Haemophilus influenzae Legionella spp*** Respiratory viruses
|
|
Pathogens for Intensive care unit (5)
|
Strepococcus pneumoniae Legionella spp Haemophilus influenzae Gram negative bacilli Staphylococcus aureus (NOT mycoplasma, chlamydia, respiratory viruses)
|
|
Pneumococcal vacc recommendations
|
high risk for pneumonia pt should get both vaccines? (PPSV23 and PCV13)
|
|
Identify individuals that are candidates for antiviral treatment of influenza
|
Suspected or confirmed influenza who are at higher risk of complications
|
|
Characteristics that indicate pt is at higher risk of complications from flu (and should get antiviral treatment) (7)
|
• Children <2yo
• Adults >65 • Pregnant and up to 2wk postpartum (including following pregnancy loss) • Chronic pulmonary, CV (except HTN), renal, hepatic, hematological, or metabolic disorders • Disorders that can compromise respiratory fxn or the handling of respiratory secretions or that can increase the risk for aspiration (eg cognitive dysfunction, neuromuscular disorders) • Immunosuppression, including those immunosuppressed in HIV med. • <19yo receiving long-term ASA therapy |
|
What is the dose and duration of treatment of influenza with oseltamivir
|
Oseltamivir 75mg BID x5
|
|
Dose duration of zanamivir and route
|
Zanamivir 10mg: 2 5mg inhalations BID x5
|
|
Signs of acute pyelonephritis (3)
|
Urinalysis and urine culture will indicate bacteriuria, pyuria, and haematuria
|
|
Symptoms of acute pyelo onset
|
develop rapidly over a few hrs or a day
|
|
Sx of acute pyelo (5)
|
High fever of 39C or greater, flank pain usually unilateral that may worsen on micturition, Rigors, N/V/D, cystitis (frequency, dysuria etc) are possible
|
|
Properties of a complicated UTI (setting they arise from, 7 other shits)
|
Complicated: arise in setting of catheterization, instrumentation, urologic anatomic or structural abnormalities, stones, immunosuppression, renal disease, diabetes, or pregnancy
|
|
Properties of uncomplicated UTI (how’s it spread)
|
infection usually spreads from bladder to ureters and kidneys
|
|
State the pathogens commonly associated with acute pyelonephritis (complicated and uncomplicated)
|
Complicated and uncomplicated: mainly Gram – enterobacteriaceae
|
|
Antimicrobial therapy for outpatient and duration
|
Outpatient: FQ x5-7 days
|
|
FQ dosing for: cipro, cipro ER< levo, moxi, oflox
|
Cipro 500mg BID, Cipro ER 1000mg QD, Levofloxacin 750mg QD, Moxifloxacin 400mg QD, or Ofloxacin 400mg BID)
|
|
Hospital therapy for pyelonephritis (uncomplicated):
|
IV FQ until afebrile for 1-2 days, then complete with oral drugs x14 days.
|
|
Oral drugs (abx) used for hospital therapy of pyelonephritis after fever is over? (1 combo, or 2 other options)
|
(Ampicillin + Gentamicin or 3rd gen cephalosporin such as ceftriaxone or Piperacillin/Tazobactam)
|
|
2
Complicated pyelonephritis treatment(5 options) and duration |
Ampicillin + Gentamicin or Ticarcillin/Clavulanic acid or Piperacillin/Tazobactam or Imipenim or Meripenim: 2-3 Weeks
|
|
Target serum conc for gentamicin and Tobramycin: (trough, peak for serous infections, and peak for synergy/UTI)
|
less than 2mcg/ml trough, 6-10mcg/ml peak for serious infections and 3-6mcg/ml peak for synergy/UTI
|
|
Amikacin target conc for trough, peak for serous infections, and peak for synergy/UTI
|
less than 10mcg/ml (trough), 20-30, and 15-20, respectively.
|
|
Calculate a loading dose, maintenance dose and dosing interval using traditional and once daily aminoglycoside dosing guidelines (Formulas will be supplied)
|
---
|
|
Recognize patients that are NOT candidates for once daily aminoglycoside dosing. (7)
|
CrCl below 60, pediatrics, ascites, dialysis, enterococcal endocarditis, pregnancy, burns >20%
|